Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy of AML in Patients Older Than 60 Years: Randomized Comparison of a Double Induction With Daunorubicin and AraC (as Continuous Infusion) With a Double Induction With Mitoxantrone and Intermittent, Medium High Dose AraC

NCT00180167 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT00180167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00180167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy of AML in Patients Older Than 60 Years: Randomized Comparison of a Double Induction With Daunorubicin and AraC (as Continuous Infusion) With a Double Induction With Mitoxantrone and Intermittent, Medium High Dose AraC
Lead sponsor
Technische Universität Dresden
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
July 31, 2010
Enrollment
492 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, nonlymphocytic, acute